Company Filing History:
Years Active: 2021
Title: Federica Sallusto: Innovator in T Cell Modulation
Introduction
Federica Sallusto is a prominent inventor based in Porza, Switzerland. She has made significant contributions to the field of immunotherapy, particularly in the modulation of T cell responses. Her innovative work has the potential to advance therapeutic strategies for various diseases.
Latest Patents
Sallusto holds a patent titled "Arginine and its use as a T cell modulator." This invention provides novel uses and methods for T cell-based immunotherapies. Specifically, it relates to novel ligands, targets, and nucleic acids, as well as vectors encoding said targets that are useful for modulating T cell responses. She has 1 patent to her name.
Career Highlights
Federica Sallusto is affiliated with the Institute for Research in Biomedicine, where she conducts her research. Her work has garnered attention for its innovative approach to immunotherapy and its implications for treating various health conditions.
Collaborations
Sallusto has collaborated with notable colleagues, including Roger Geiger and Antonio Lanzavecchia. These partnerships have further enriched her research and contributed to advancements in the field.
Conclusion
Federica Sallusto's contributions to T cell modulation represent a significant advancement in immunotherapy. Her innovative patent and collaborative efforts highlight her role as a leading inventor in this critical area of research.